Retatrutide is not available as a licensed treatment through the NHS, and any use outside of an approved clinical trial would be considered unlicensed
This isn't just a casual recommendation
Because these procedures permanently change digestion, bariatric patients usually require lifelong attention to protein intake, hydration, supplementation, and structured eating habits
Scientific understanding of GLP-1 and the roles it plays in promoting a healthy blood glucose response and weight management is on-going
As of early 2026, retatrutide is not yet FDA approved
Any microdose schedulewhether it involves microdose semaglutide or tirzepatideshould come from a licensed prescriber using approved products from legitimate pharmacies, with clear instructions and close follow-up